Founded by clinical experts
ProductsLeadershipMilestonesVisibility
Medical physics PhDs from national cancer centers and university hospitals — people who built what they needed.
Vision
Innovating the radiation therapy technology through clinical practice
Founded in 2021 by medical physicists and radiation oncology experts from major Korean medical institutions, RaphaRAD develops advanced brachytherapy and proton therapy technology alongside QA and protection products ready for clinical use today.
This page contains only publicly verifiable information and does not imply undisclosed revenue, regulatory approvals, or market share.
Company overview
What is RaphaRAD?
Based on publicly available facts about RaphaRAD's current position.
Founded by clinical experts
ProductsLeadershipMilestonesVisibility
Medical physics PhDs from national cancer centers and university hospitals — people who built what they needed.
Six-product portfolio across three areas
RevenueApprovalInstalled baseShare
QA and protection products generating revenue today. Brad-FIT, Pro-MI, and Gold-DOT driving the next growth phase.
Why RaphaRAD
Four reasons RaphaRAD stands out
The case for RaphaRAD — grounded in products, team, and execution history.
01
Portfolio breadth across multiple radiation therapy layers
02
Founding and leadership credibility
03
Visible execution signals since 2021
04
Room to deepen evidence over time
Business Model
Not a one-time sale — a recurring revenue structure
Hardware sales, software licenses, and consumable reorders combine to create repeating revenue.
01
Hardware / Equipment Sales
Brad-FIT · Pro-MI · BIM · LIM · Lens-OK
→
02
Software License
BIM automated analysis software · Periodic updates
→
03
Consumable Reorders
Gold-DOT (proportional to treatment volume)
When a radiation therapy center adopts BIM, LIM are reordered continuously in proportion to treatment volume. This structure converts a single sale into ongoing revenue.
Execution Record
Proven by record, not by claim
Every year since 2021, a publicly verifiable milestone has been added.
Past
2021.042021.052021.11
RaphaRAD founded
Past
First QA product launches
Current
20232024
Operational and program expansion
Current
2025.09
Continued conference and market presence
Next
Next public milestones
Partners & Collaborators
Institutions and organizations working alongside RaphaRAD
Collaborator
DK Medical Solutions
Collaborator
National Cancer Center
Institutional collaborator
Keimyung University Dongsan Medical Center
Institutional collaborator
The University of Texas MD Anderson Cancer Center
Partner institution
Wonkwang University
Commercial collaborator
Anzai Medical
Commercial collaborator
